The six main genes are involved in the cancer and inflammatory processes (YWHAZ, CCL2 and SMPD2) and lipid droplet formation and metabolism (CIDEC, VLDLR and FASN) and significantly increased in NASH patients compared to control or NAFL groups (Figure 8C). Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.